Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels

SIMPLE SUMMARY: Neoadjuvant chemotherapy is used in patients with initially unresectable advanced ovarian cancer (AOC) to reduce the disease bulk. The CA-125 level depends on tumor burden changes. A joint model (JM) is a statistical tool used for dynamic prediction during follow-up. A JM of longitud...

Descripción completa

Detalles Bibliográficos
Autores principales: Amroun, Koceila, Chaltiel, Raphael, Reyal, Fabien, Kianmanesh, Reza, Savoye, Aude-Marie, Perrier, Marine, Djerada, Zoubir, Bouché, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818430/
https://www.ncbi.nlm.nih.gov/pubmed/36612234
http://dx.doi.org/10.3390/cancers15010231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818430/
https://www.ncbi.nlm.nih.gov/pubmed/36612234
http://dx.doi.org/10.3390/cancers15010231

Ejemplares similares